📱 Now on iPhone — live scores, valuations & alerts on the go
Create an account for unlimited access
Akebia Therapeutics, Inc. (AKBA)
Healthcare
Inconclusive
mixed
$0.97
Updated: 2026-08-31
55
TradeApes Score
Financial Strength
64
Healthy
Operating Trend
77
Strong
Relative Value
41
Overvalued
Capital Allocation
38
Weak
Risk Management
56
Mixed
Key Findings
+
operating-margin trend + inflection
−
ev_to_ebitda vs sector peers
Industry Related Stocks
Get AKBA and 3,000+ stocks in your pocket
Health scores, fair-value estimates, and full company analysis — free on iPhone.
Download iPhone App
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.